AIFM2/FSP1 blocks erastin-, sorafenib-, and RSL3-induced ferroptotic cancer cell death through a mechanism independent of ubiquinol, the reduced and active antioxidant form of coenzyme Q10 [42,43,52]. The gene discussed is AIFM2; the disease is cancer.